معرفی
Professor Patrick Kwan is a clinician-researcher and international authority in epileptology and antiepileptic drug development. He holds the position of Professor of Neurology in the Department of Neuroscience at Monash University's School of Translational Medicine and serves as Co-Director of the Monash Institute of Medical Engineering. Clinically, he is a Consultant Neurologist at Alfred Health, specializing in epilepsy. He is a Fellow of the Australian Academy of Health and Medical Sciences and previously chaired the Medical Therapies Commission of the International League Against Epilepsy (2013–2017).
Education:
- Clinical Medicine (MB, BChir), University of Cambridge
- PhD in Medicine and Therapeutics, University of Glasgow
- BMedSci in Preclinical Medicine, University of Nottingham
Research Interests:
- AI models for epilepsy treatment prediction and ethical implications
- Stem cell-derived neuronal platforms for personalized drug discovery
- Biosensors for point-of-care diagnostics
- Wearable sensors for seizure monitoring
His research integrates genomics, stem cells, bioengineering, and AI to achieve personalized epilepsy management. He leads a multidisciplinary team with collaborations across academia, hospitals, and MedTech industries.
Awards:
- Fellow of the Australian Academy of Health and Medical Sciences
- Developing Predictive Biomarkers of Epilepsy Seizures (2016)
Grants & Projects:
- BrainAssure: Electrochemical sensor platform for brain health monitoring (2025–2026)
- Diagnosing brain bleed using a drop of blood (2025–2027)
- EEG biomarkers for altered consciousness (2024–2025)
Labs/Teams: Kwan Lab at Monash University, focusing on precision medicine and engineering solutions for neurological disorders.
